Jefferies Financial Group Lowers Safran (SAFRY) to Underperform

Share on StockTwits

Jefferies Financial Group lowered shares of Safran (OTCMKTS:SAFRY) from a hold rating to an underperform rating in a research note issued to investors on Wednesday, October 17th, The Fly reports. Jefferies Financial Group also issued estimates for Safran’s FY2018 earnings at $1.35 EPS, FY2019 earnings at $1.74 EPS and FY2020 earnings at $2.18 EPS.

Several other brokerages have also weighed in on SAFRY. Zacks Investment Research lowered Safran from a buy rating to a hold rating in a report on Thursday, August 16th. Deutsche Bank raised Safran from a hold rating to a buy rating in a report on Friday, September 7th. Finally, Sanford C. Bernstein raised Safran from a market perform rating to an outperform rating in a report on Monday, September 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of Hold.

OTCMKTS:SAFRY traded down $0.61 during mid-day trading on Wednesday, hitting $31.85. The company had a trading volume of 86,394 shares, compared to its average volume of 84,272. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.86 and a quick ratio of 0.59. Safran has a 1 year low of $24.82 and a 1 year high of $35.77. The firm has a market capitalization of $57.78 billion, a PE ratio of 17.99, a price-to-earnings-growth ratio of 2.19 and a beta of 0.79.

Safran Company Profile

Safran SA, together with its subsidiaries, engages in the aerospace and defense businesses worldwide. The company operates through three segments: Aerospace Propulsion, Aircraft Equipment, and Defense. The Aerospace Propulsion segment designs, develops, produces, and markets propulsion systems for commercial aircraft, military transport, training and combat aircraft, rocket engines, civil and military helicopters, and tactical missiles and drones.

See Also: Do You Need a Fiduciary?

The Fly

Receive News & Ratings for Safran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safran and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.